Advertisement
U.S. markets closed

Amneal Pharmaceuticals, Inc. (AMRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
8.39+0.07 (+0.84%)
At close: 04:00PM EST
8.27 -0.12 (-1.43%)
After hours: 07:47PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,680,420
2,393,607
2,212,304
2,093,669
1,992,523
Cost of Revenue
1,733,028
1,573,042
1,427,596
1,324,696
1,364,130
Gross Profit
947,392
820,565
784,708
768,973
628,393
Operating Expense
668,569
596,315
595,786
575,067
517,312
Operating Income
278,823
224,250
188,922
193,906
111,081
Net Non Operating Interest Income Expense
-297,286
-251,434
-158,668
-136,325
-145,998
Other Income Expense
-104,692
-13,086
-278,381
-26,215
-863
Pretax Income
-123,155
-40,270
-248,127
31,366
-35,780
Tax Provision
23,323
8,452
6,662
11,196
-104,358
Net Income Common Stockholders
-184,454
-83,993
-129,986
10,624
91,059
Diluted NI Available to Com Stockholders
-184,454
-83,993
-129,986
10,624
91,059
Basic EPS
0.07
-0.48
-0.86
0.07
0.62
Diluted EPS
0.06
-0.48
-0.86
0.07
0.61
Basic Average Shares
152,893
176,136
150,944
148,922
147,443
Diluted Average Shares
155,083
176,136
150,944
151,821
148,913
Total Operating Income as Reported
187,726
204,374
-94,928
152,716
91,155
Total Expenses
2,401,597
2,169,357
2,023,382
1,899,763
1,881,442
Net Income from Continuing & Discontinued Operation
-184,454
-83,993
-129,986
10,624
91,059
Normalized Income
-95,338
-69,611
104,023
37,337
93,580
Interest Expense
256,481
210,629
158,377
136,325
145,998
Net Interest Income
-297,286
-251,434
-158,668
-136,325
-145,998
EBIT
133,326
170,359
-89,750
167,691
110,218
EBITDA
360,320
399,759
150,425
401,097
345,605
Reconciled Cost of Revenue
1,733,028
1,573,042
1,427,596
1,324,696
1,364,130
Reconciled Depreciation
226,994
229,400
240,175
233,406
235,387
Net Income from Continuing Operation Net Minority Interest
-184,454
-83,993
-129,986
10,624
91,059
Total Unusual Items Excluding Goodwill
-112,805
-18,205
-296,214
-41,545
-3,453
Total Unusual Items
-112,805
-18,205
-296,214
-41,545
-3,453
Normalized EBITDA
473,125
417,964
446,639
442,642
349,058
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-23,689
-3,823
-62,205
-14,832
-932.31